Contact
searchSearch
HMP Global

HIV PrEP

Featured Article

News
HIV Cases Rise Among Gay Latinos
07/24/2024
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise...
07/24/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
Study Estimates Billable Per Patient Costs of Providing PrEP
12/20/2022
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing...
12/20/2022
First Report Managed Care
News
Women View PrEP Services as a Natural Extension of OB/GYN Care
11/17/2022
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested...
11/17/2022
First Report Managed Care
News
Black Sexual Minority Men Report Higher Prevalence of PrEP Use Than White Men
11/14/2022
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey...
11/14/2022
First Report Managed Care
News
PrEP Most Effective for Reducing HIV Incidence in Men Who Have Sex With Men
11/07/2022
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of...
11/07/2022
First Report Managed Care
News
Positive Sources of PrEP Awareness Include Partners, Peers, Health Promotions
09/27/2022
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns...
09/27/2022
First Report Managed Care
News
Monitoring HIV Strains to Prevent PrEP Failure, Viral Transmission
09/09/2022
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a...
09/09/2022
First Report Managed Care
News
High Distress in Black MSM Lowers Odds of Antiretroviral Therapy Adherence
09/02/2022
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological...
09/02/2022
First Report Managed Care
News
Social Support Affects PrEP Use in Black Sexual Minority Individuals Experiencing Discrimination
07/29/2022
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some...
07/29/2022
First Report Managed Care
News
Identifying Barriers to PrEP Uptake, Adherence for Transgender Patients
07/22/2022
Lack of trust in the health care system and concerns over medication interactions were among several barriers to PrEP adherence for transgender patients in the United States.
Lack of trust in the health care system and concerns over medication interactions were among several barriers to PrEP adherence for transgender patients in the United States.
Lack of trust in the health care...
07/22/2022
First Report Managed Care

Newsfeed

News
HIV Cases Rise Among Gay Latinos
07/24/2024
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise among Latino gay and bisexual men, health policy advocates stress the need for more federal assistance for HIV treatment and prevention in this community.
As HIV rates continue to rise...
07/24/2024
First Report Managed Care
News
Injectable PrEP Overall Acceptable, Preferred for HIV Prevention
07/15/2023
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability, injectable PrEP should be included as part of a menu of prevention options, allowing end-users to select the modality that suits their preferences, needs and lifestyle,” researchers advised.
“Given overall acceptability,...
07/15/2023
First Report Managed Care
News
Study Estimates Billable Per Patient Costs of Providing PrEP
12/20/2022
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing records in Washington, DC and Chicago to estimate the annual billable costs associated with the use of preexposure prophylaxis for HIV.
Researchers used clinic billing...
12/20/2022
First Report Managed Care
News
Women View PrEP Services as a Natural Extension of OB/GYN Care
11/17/2022
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested that initial counseling on PrEP should be offered universally to patients, regardless of sexual history or personal risk factors,” researchers advised.
“Multiple participants suggested...
11/17/2022
First Report Managed Care
News
Black Sexual Minority Men Report Higher Prevalence of PrEP Use Than White Men
11/14/2022
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey to determine how prevalent the use of pre- and post-exposure prophylaxis was among over 63,000 participants.
Investigators conducted a survey...
11/14/2022
First Report Managed Care
News
PrEP Most Effective for Reducing HIV Incidence in Men Who Have Sex With Men
11/07/2022
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of interventions, pre-exposure prophylaxis was the only method that showed consistent effectiveness in reducing the incidence of HIV, new findings show.
Among a variety of...
11/07/2022
First Report Managed Care
News
Positive Sources of PrEP Awareness Include Partners, Peers, Health Promotions
09/27/2022
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns were perceived as most positive, and those from religious institutions as least positive," authors said.
"Messages from health campaigns...
09/27/2022
First Report Managed Care
News
Monitoring HIV Strains to Prevent PrEP Failure, Viral Transmission
09/09/2022
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a strategy to monitor populations for HIV strains that are resistant to tenofovir and emtricitabine and ensure PrEP failure rates remain rare.
Study authors employed a...
09/09/2022
First Report Managed Care
News
High Distress in Black MSM Lowers Odds of Antiretroviral Therapy Adherence
09/02/2022
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological distress may represent an important barrier against HIV treatment adherence for Black men who have sex with men living in urban areas, researchers said.
High rates of psychological...
09/02/2022
First Report Managed Care
News
Social Support Affects PrEP Use in Black Sexual Minority Individuals Experiencing Discrimination
07/29/2022
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some unanticipated relationships, they provide insight into how discrimination and stigma may influence PrEP use and disparities," researchers said.
"While our findings showed some...
07/29/2022
First Report Managed Care
News
Using Deep Learning to Measure MS-Specific Brain Damage Beyond Aging
11/11/2024
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in...
11/11/2024
First Report Managed Care
News
Adverse Event Data Suggest Selective β1-blockers Pose Asthma Risk
11/11/2024
The risks of asthma and asthma-like adverse events appear to be higher with selective β1-blockers than with nonselective blockers and α- and β-blockers.
The risks of asthma and asthma-like adverse events appear to be higher with selective β1-blockers than with nonselective blockers and α- and β-blockers.
The risks of asthma and...
11/11/2024
First Report Managed Care
News
RNAi Therapies Offer New Hope for Patients With Hereditary Transthyretin Amyloidosis
11/08/2024
RNA interference (RNAi)-based treatments for hereditary transthyretin amyloidosis (ATTR) have shown remarkable promise, offering new hope for patients with this rare but devastating genetic disorder.
RNA interference (RNAi)-based treatments for hereditary transthyretin amyloidosis (ATTR) have shown remarkable promise, offering new hope for patients with this rare but devastating genetic disorder.
RNA interference (RNAi)-based...
11/08/2024
First Report Managed Care
News
Revolutionary Single-Dose Gene Therapy Offers New Hope for Adults with Hemophilia B
11/08/2024
A groundbreaking gene therapy for hemophilia B has shown remarkable success in reducing bleeding episodes and improving the quality of life for adult patients, according to a recent international phase III clinical trial.
A groundbreaking gene therapy for hemophilia B has shown remarkable success in reducing bleeding episodes and improving the quality of life for adult patients, according to a recent international phase III clinical trial.
A groundbreaking gene therapy...
11/08/2024
First Report Managed Care
News
Real-World Evidence Supports Efficacy and Safety of Selexipag in Patients With Pulmonary Arterial Hypertension
11/07/2024
Real-world data shows selexipag effectively improves functional class and risk category outcomes in patients with pulmonary arterial hypertension, regardless of maintenance dose.
Real-world data shows selexipag effectively improves functional class and risk category outcomes in patients with pulmonary arterial hypertension, regardless of maintenance dose.
Real-world data shows selexipag...
11/07/2024
First Report Managed Care
News
Clinical Predictors of One-Year Seizure Freedom After SLAH
11/06/2024
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of...
11/06/2024
First Report Managed Care
News
Efficacy and Outcomes of Neoadjuvant Immunotherapy in Lung Cancer
11/05/2024
A meta-analysis of 43 studies suggests that neoadjuvant chemoimmunotherapy may benefit patients with resectable NSCLC and low tumor PD-L1 levels for event-free survival, showing superior outcomes compared to neoadjuvant chemotherapy.
A meta-analysis of 43 studies suggests that neoadjuvant chemoimmunotherapy may benefit patients with resectable NSCLC and low tumor PD-L1 levels for event-free survival, showing superior outcomes compared to neoadjuvant chemotherapy.
A meta-analysis of 43 studies...
11/05/2024
First Report Managed Care
News
FDA Grants Accelerated Approval for Asciminib as First-Line Treatment in Ph+CML-CP
11/01/2024
Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).
Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).
Novartis received accelerated...
11/01/2024
First Report Managed Care
News
HHS Faces Legal Action From 10 Hospitals Over 2023 Medicare Advantage Rule and Reimbursement Calculations
10/30/2024
Ten hospitals sued the US Department of Health and Human Services (HHS), claiming that they were underpaid Medicare reimbursements for serving low-income patients.
Ten hospitals sued the US Department of Health and Human Services (HHS), claiming that they were underpaid Medicare reimbursements for serving low-income patients.
Ten hospitals sued the US...
10/30/2024
First Report Managed Care
News
Impact of Immune Checkpoint Inhibitors on Multiple Sclerosis Treatment Outcomes
10/29/2024
Relapses and progression of multiple sclerosis were rare in patients treated with immune checkpoint inhibitors, according to a study presented at the American Academy of Neurology 2024 Annual Meeting.
Relapses and progression of multiple sclerosis were rare in patients treated with immune checkpoint inhibitors, according to a study presented at the American Academy of Neurology 2024 Annual Meeting.
Relapses and progression of...
10/29/2024
First Report Managed Care

Insights

Headshot of Brian Mustanski, Northwestern University
Interview
Insurance Coverage, Relationship Status, Other Factors Linked to PrEP Reinitiation
04/14/2022
Brian Mustanski, PhD, professor of medical social sciences, Northwestern University, shares factors influencing whether patients reinitiate preexposure prophylaxis for HIV after discontinuation.
Brian Mustanski, PhD, professor of medical social sciences, Northwestern University, shares factors influencing whether patients reinitiate preexposure prophylaxis for HIV after discontinuation.
Brian Mustanski, PhD, professor...
04/14/2022
First Report Managed Care
Chris Beyrer
Podcasts
PrEP in the United States Faces Slow Uptake and Coverage Among Payers
06/30/2021
Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health, breaks down current rates of HIV across the United States as well as the challenges linked with controlling this...
Chris Beyrer, MD, infectious disease epidemiologist and professor at Johns Hopkins Bloomberg School of Public Health, breaks down current rates of HIV across the United States as well as the challenges linked with controlling this...
Chris Beyrer, MD, infectious...
06/30/2021
First Report Managed Care
Addressing Barriers to Preventive HIV Care for At-Risk Patient Populations
Podcasts
Addressing Barriers to Preventive HIV Care for At-Risk Patient Populations
01/25/2021
Ed Pezalla, MD, CEO, Enlightenment Bioconsult LLC, speaks about the barriers to preventive HIV care, pinpoints how payers can reach at-risk populations, and reviews the US Preventive Services Task Force’s measures requiring health plans to...
Ed Pezalla, MD, CEO, Enlightenment Bioconsult LLC, speaks about the barriers to preventive HIV care, pinpoints how payers can reach at-risk populations, and reviews the US Preventive Services Task Force’s measures requiring health plans to...
Ed Pezalla, MD, CEO,...
01/25/2021
First Report Managed Care
Examining a New Class of Antiretroviral Therapy for Patients With Multidrug-Resistant HIV-1 Infection
Videos
Examining a New Class of Antiretroviral Therapy for Patients With Multidrug-Resistant HIV-1 Infection
09/23/2020
Max Lataillade, DO, head of global research strategy, ViiV Healthcare, discusses the findings of the BRIGHTE study that demonstrated a significant decrease in HIV-1 RNA levels among patients treated with fostemsavir, a first-in-class...
Max Lataillade, DO, head of global research strategy, ViiV Healthcare, discusses the findings of the BRIGHTE study that demonstrated a significant decrease in HIV-1 RNA levels among patients treated with fostemsavir, a first-in-class...
Max Lataillade, DO, head of...
09/23/2020
First Report Managed Care

Related Content

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use